000
| 01558nam 2200325zi 4500 |
---|
001 | 9.933514 |
---|
003 | CaOODSP |
---|
005 | 20240503153350 |
---|
006 | m o d f |
---|
007 | cr |n||||||||| |
---|
008 | 240206e202101 onc ob f000 0 eng d |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH14-561/2021E-PDF |
---|
245 | 00|aAudit of the controlled substances program at Health Canada : |bfinal report. |
---|
264 | 0|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cJanuary 2021. |
---|
300 | |a1 online resource (30 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Audit du Programme des substances contrôlées de Santé Canada : rapport définitif. |
---|
504 | |aIncludes bibliographical references. |
---|
610 | 10|aCanada. |bHealth Canada|xAuditing. |
---|
650 | 0|aPharmaceutical policy|zCanada|xAuditing. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
775 | 08|tAudit du Programme des substances contrôlées de Santé Canada : |w(CaOODSP)9.937747 |
---|
856 | 40|qPDF|s807 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-561-2021-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/internal-audits/controlled-substances-program-2021.html |
---|